The Spanish government has folded a nationwide tech transfer body into the central science foundation, ending a decade of special treatment for the biotech community. The Foundation for Genomic and Proteomic Development and Investigation, better known as Genoma España, was set up in 2002 in Madrid by the Spanish Science Ministry to incubate biotech businesses. Now its €4.5 ($6.2)-million budget is unlikely to go with it, Spanish science news outlet Materia reports. Continue reading Spain nudges biotech from nest
Tag Archives: Biotechnology
Forty fight rust and rot
More than 40 institutes around the world are teaming up to use biotech tools to improve food security in sub-Saharan Africa and India. The Sustainable Crop Production Research for International Development (SCPRID) will provide a total £16 ($25.5) million for 11 projects aimed at developing crops that will resist pests or survive in harsh environments. Continue reading Forty fight rust and rot
BASF moves GM crop research to US
BASF Plant Science is relocating from its European headquarters to the US, a move prompted by the European public’s hostility to genetically modified (GM) crops, its president Peter Eckes said. The German company is also cancelling the development and commercialization of all projects destined solely for the European market and in future will concentrate on markets in America and Asia. Continue reading BASF moves GM crop research to US
Transatlantic PML
The European Medicine Agency and US Food and Drug Administration (FDA) published in September the proceedings of a joint workshop held to address questions related to progressive multifocal leukoencephalopathy (PML), a rare and sometimes fatal brain disease that can occur as an adverse drug reaction to some therapeutics that affect immunological functions. The meeting attended by 170 regulators, academic scientists, funding bodies and clinical researchers, called for work on animal models, predictive biomarkers and long-term studies. “No one company is going to answer all the questions; they’re going to be answered by research consortia,” says co-convener and European Medicines Agency (EMA) pharmacovigilance head Peter Arlett. Continue reading Transatlantic PML